Breast Cancer Screening
Find information on Breast Cancer Screening, also known as Mammogram Screening or simply Breast Screening. This resource offers guidance on healthcare documentation, clinical coding, and medical billing related to breast cancer screening procedures. Learn about ICD-10 codes, CPT codes, and best practices for accurate clinical documentation for mammograms and other breast imaging studies. Improve your understanding of breast cancer screening guidelines and ensure proper medical coding for optimal reimbursement and patient care.
Screening for breast cancer in asymptomatic women to detect early signs.
Usually asymptomatic. Screening detects abnormalities like masses or calcifications.
Outpatient radiology clinics, mobile mammography units, hospitals.
ICD-10 Code Families
Complete code families applicable to Z12.31
When to use each related code
| Description | When to use |
|---|---|
| Screening for breast cancer in asymptomatic women. | For routine breast cancer screening in average-risk women. Consider risk factors and guidelines. |
| Evaluation of a palpable breast lump or other breast symptoms. | For patients with breast symptoms like lumps, nipple discharge, or skin changes. Not for routine screening. |
| Follow-up imaging for abnormal breast screening results. | For further evaluation of suspicious findings on mammography, ultrasound, or MRI. Not for initial screening. |
Best-practice checklist
- ✓Patient's age and date of birth
- ✓Date and type of mammogram (screening/diagnostic)
- ✓Breast density (BI-RADS classification)
- ✓Relevant medical history (family history, prior biopsies)
- ✓Clinical breast exam findings (if performed)
Common pitfalls to avoid
Missing or incorrect laterality (right, left, bilateral) for breast cancer screening can impact reimbursement and quality metrics.
Miscoding a diagnostic mammogram as a screening mammogram or vice versa leads to claim denials and inaccurate reporting.
Incorrectly billing separate codes for components of a mammogram when a comprehensive code exists leads to overbilling issues.
Best-practice tips
- 01Annual mammograms starting at age 40. ICD-10 Z12.31
- 02High-risk patients: MRI + mammogram. SNOMED CT 709041001
- 03Document family history, risk factors for accurate risk assessment. HCC188
- 04Timely follow-up on abnormal findings. CPT 77055
- 05Patient education on breast self-awareness. ICD-10 Z71.89
Step-by-step checklist
- 1
Verify patient age and risk factors (ICD-10 Z12.31)
- 2
Confirm recent mammogram date/results (SNOMED CT 709041007)
- 3
Assess family history of breast cancer (ICD-10 Z80.3)
- 4
Document breast density and exam findings (LOINC 38568-6)
Ready-to-paste narrative
Patient presents for routine breast cancer screening (mammogram screening). The patient reports no current breast complaints, such as breast pain, nipple discharge, skin changes, or palpable lumps. She denies any family history of breast cancer. Menarche was at age 12, and she is currently G0P0. She is not currently using hormonal birth control or hormone replacement therapy. Physical examination reveals no palpable breast masses, lymphadenopathy, or skin abnormalities. Assessment: Breast screening indicated. Plan: Order bilateral mammogram. Patient education provided regarding breast self-examination and the importance of regular breast screenings. Follow-up will be scheduled to review mammogram results and discuss further management as needed. ICD-10 code Z12.31 (Encounter for screening mammogram for malignant neoplasm of breast) will be used for billing purposes. Differential diagnoses include fibrocystic breast changes, breast cysts, and other benign breast conditions. Further evaluation will be guided by mammogram findings and patient symptoms. Keywords: breast cancer screening, mammogram, breast exam, breast health, early detection, breast pain, nipple discharge, breast lump, breast self-exam, radiology, diagnostic imaging, preventive care, women's health, asymptomatic, risk factors, family history, hormone therapy, clinical breast exam, CBE, physical exam, billing codes, ICD-10, medical coding, EHR documentation, patient education, follow-up care.
Common questions and answers
What are the current American Cancer Society (ACS) guidelines for breast cancer screening with mammography for average-risk women, and how can I effectively communicate these recommendations to my patients?+
The American Cancer Society recommends that women at average risk for breast cancer begin yearly mammograms at age 45. Women aged 40-44 should have the option to start annual screening. At age 55, women can transition to mammograms every two years, or continue yearly screening. Screening should continue as long as a woman is in good health and has a life expectancy of 10 years or longer. Effectively communicating these guidelines involves shared decision-making, discussing the benefits and harms of screening, addressing individual risk factors, and respecting patient preferences. Explore how patient decision aids can facilitate these conversations and improve adherence to recommended screening protocols. Consider implementing standardized communication strategies to ensure consistent messaging across your practice.
How do I interpret dense breast tissue on a mammogram report, and what are the implications for breast cancer risk and screening strategies in patients with dense breasts?+
Dense breast tissue appears white on a mammogram, making it harder to detect cancer which also appears white. This can lead to false negatives. Having dense breasts increases breast cancer risk (though the magnitude of this risk is still being studied). When communicating with patients, explain that dense breast tissue is a common finding, not a disease. While mammography remains the primary screening tool, supplemental screening with ultrasound, MRI, or molecular breast imaging may be considered for women with dense breasts, particularly those with additional risk factors. Learn more about the density reporting legislation in your state and discuss the potential benefits and limitations of supplemental screening with your patients. Consider implementing a risk assessment tool to help guide decisions about supplemental screening based on individual risk profiles.
What are the best practices for managing abnormal breast cancer screening results, including false positives, and providing patient-centered follow-up care?+
Managing abnormal breast cancer screening results requires a clear and compassionate approach. Start by explaining the finding to the patient, emphasizing that an abnormal result does not necessarily mean cancer. Outline the next steps, which might include diagnostic mammogram, ultrasound, biopsy, or MRI. Provide emotional support and manage patient anxiety during this period of uncertainty. False positives are common and can cause undue stress, so ensure patients understand the likelihood of benign findings. Follow-up care is crucial. Ensure timely communication of results and referrals to specialists if needed. Provide educational resources and support networks to help patients navigate the diagnostic process. Learn more about effective communication strategies for delivering difficult news and explore how multidisciplinary care teams can improve patient outcomes in cases of confirmed breast cancer diagnosis.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.